Ignite Creation Date:
2025-12-25 @ 12:03 AM
Ignite Modification Date:
2025-12-25 @ 10:01 PM
Study NCT ID:
NCT03246958
Status:
COMPLETED
Last Update Posted:
2025-06-19
First Post:
2017-08-08
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Nivolumab Plus Ipilimumab in Thyroid Cancer
Sponsor:
Dana-Farber Cancer Institute
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-10-03
Start Date Type:
ACTUAL
Primary Completion Date:
2021-01-21
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-07-31
Completion Date Type:
ACTUAL
First Submit Date:
2017-08-08
First Submit QC Date:
None
Study First Post Date:
2017-08-11
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2023-09-23
Results First Submit QC Date:
None
Results First Post Date:
2024-05-21
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-06-05
Last Update Post Date:
2025-06-19
Last Update Post Date Type:
ACTUAL